Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 27, 2025 08:47 ET | Source: Research and Markets

CD73 Inhibitors Pipeline Report 2025: an Up-to-date Competitor Evaluation in the Field of Antibodies, RNA and Small Molecules in Research and Development Inhibiting CD73

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of CD73 Inhibitors" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about CD73 Inhibitors...
November 27, 2025 08:29 ET | Source: Research and Markets

Nectin-4-Targeted Immunotherapies Pipeline and Competitive Intelligence Report 2025

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of Nectin-4-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
November 27, 2025 08:24 ET | Source: Research and Markets

EpCAM-Targeted Immunotherapies Pipeline and Competitive Intelligence Report 2025

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of EpCAM-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
November 10, 2025 07:30 ET | Source: Lyell Immunopharma, Inc

Lyell Immunopharma Acquires Exclusive Global Rights to a Next-Generation CAR T-Cell Product Candidate in Clinical Development for Metastatic Colorectal Cancer

LYL273 has demonstrated a 67% overall response rate, an 83% disease control rate, and a manageable safety profile at the highest dose level studied to date in patients with refractory metastatic...
August 15, 2025 16:15 ET | Source: Jabez Biosciences, Inc.

Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001

Jabez Biosciences Announces Opening of Second Clinical Site in Phase 1 study in Solid Tumors and NHL
July 30, 2025 04:20 ET | Source: Research and Markets

CAR/TCR/TIL Therapies in Oncology Research Service 2025 | An Essential Tool to Navigate the Fast-evolving Cancer Treatment Landscape

Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Unlocking Opportunity: Dominate the Market of CAR/TCR/TIL Therapies in Oncology with Confidence" directory has been added to ResearchAndMarkets.com's...
May 08, 2025 04:22 ET | Source: Research and Markets

Anti-Cancer MAbS Market Research Report 2025: Rising Cancer Incidence Spurs Demand for Targeted Anti-Cancer MAbS Treatments - Historic Trends and Forecasts, 2019-2024, 2024-2029F, 2034F

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Anti-Cancer MAbS Market Report 2025" has been added to ResearchAndMarkets.com's offering. The anti-cancer monoclonal antibodies (mAbs) market is...
January 27, 2025 04:29 ET | Source: Research and Markets

2024 Research: Global Invasive Ductal Carcinoma Treatment Market Set to Reach $23.02 Billion by 2034, - Rising Prevalence of Breast Cancer Fuels Advancements in Personalized Medicine

Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "Invasive Ductal Carcinoma Treatment Market by Therapy, by Type, by Distribution Channel, and By Region" report has been added to ...
January 09, 2025 04:01 ET | Source: Research and Markets

Oncology Based in-Vivo CRO Business Research Report 2024: Global Market to Reach $2.5 Billion by 2030 - Expansion in Drug Discovery, Translational Research, and Toxicology Fuels Growth

Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Oncology Based in-Vivo CRO - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
March 07, 2024 12:09 ET | Source: Research and Markets

Oncology-Based In-Vivo CRO Market Projected for Vigorous Growth, North America Leads Regional Shares

Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Oncology-based In-Vivo CRO Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global Industry Anticipates Major...